AOTI Inc (AOTI) - Net Assets
Based on the latest financial reports, AOTI Inc (AOTI) has net assets worth GBX17.74 Million GBX (≈ $2.16K USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX54.38 Million ≈ $6.62K USD) and total liabilities (GBX36.64 Million ≈ $4.46K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check tangible equity quality of AOTI Inc to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | GBX17.74 Million |
| % of Total Assets | 32.63% |
| Annual Growth Rate | 307.08% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 747.3 |
AOTI Inc - Net Assets Trend (2021–2024)
This chart illustrates how AOTI Inc's net assets have evolved over time, based on quarterly financial data. See AOTI Inc (AOTI) defensive interval to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for AOTI Inc (2021–2024)
The table below shows the annual net assets of AOTI Inc from 2021 to 2024. For live valuation and market cap data, see AOTI Inc (AOTI) total market value.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | GBX17.44 Million ≈ $2.12K |
+395.07% |
| 2023-12-31 | GBX-5.91 Million ≈ $-719.17 |
-273.18% |
| 2022-12-31 | GBX3.41 Million ≈ $415.27 |
+1221.42% |
| 2021-12-31 | GBX258.29K ≈ $31.43 |
-- |
Equity Component Analysis
This analysis shows how different components contribute to AOTI Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1701.2% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | GBX1.00K | 0.01% |
| Other Components | GBX35.09 Million | 201.17% |
| Total Equity | GBX17.44 Million | 100.00% |
AOTI Inc Competitors by Market Cap
The table below lists competitors of AOTI Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Zephyr Energy PLC
LSE:ZPHR
|
$766.79K |
|
B Yair Building Corporation 1988 Ltd
TA:BYAR
|
$768.74K |
|
Sentoria Group Bhd
KLSE:5213
|
$770.00K |
|
T-Bull S.A
WAR:TBL
|
$771.81K |
|
Portofino Resources Inc
V:POR
|
$761.48K |
|
Arkle Resources PLC
STU:48O
|
$760.55K |
|
Omkar Speciality Chemicals Limited
NSE:OMKARCHEM
|
$758.87K |
|
Ecoclime Group AB Series B
ST:ECC-B
|
$757.53K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in AOTI Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -5,910,813 to 17,441,000, a change of 23,351,813.
- Net loss of 1,756,000 reduced equity.
- New share issuances of 24,735,000 increased equity.
- Other factors increased equity by 372,813.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | GBX-1.76 Million | -10.07% |
| Share Issuances | GBX24.73 Million | +141.82% |
| Other Changes | GBX372.81K | +2.14% |
| Total Change | GBX- | % |
Book Value vs Market Value Analysis
This analysis compares AOTI Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 359.80x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 4118.32x to 359.80x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | GBX0.01 | GBX59.00 | x |
| 2022-12-31 | GBX0.01 | GBX59.00 | x |
| 2023-12-31 | GBX-0.06 | GBX59.00 | x |
| 2024-12-31 | GBX0.16 | GBX59.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently AOTI Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -10.07%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -3.01%
- • Asset Turnover: 1.48x
- • Equity Multiplier: 2.27x
- Recent ROE (-10.07%) is above the historical average (-61.49%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | 133.03% | 8.82% | 15.23x | 0.99x | GBX1.87 Million |
| 2022 | -368.92% | -8.37% | 3.58x | 12.30x | GBX-2.88 Million |
| 2023 | 0.00% | -18.64% | 2.08x | 0.00x | GBX-7.60 Million |
| 2024 | -10.07% | -3.01% | 1.48x | 2.27x | GBX-3.50 Million |
Industry Comparison
This section compares AOTI Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $365,183,044
- Average return on equity (ROE) among peers: -84.72%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| AOTI Inc (AOTI) | GBX17.74 Million | 133.03% | 2.06x | $761.69K |
| Creo Medical Group PLC (CREO) | $-12.00K | 0.00% | 0.00x | $683.79K |
| EKF Diagnostics Holdings Plc (EKF) | $46.75 Million | -79.40% | 0.54x | $1.40 Million |
| Inspiration Healthcare Group PLC (IHC) | $3.12 Million | 9.98% | 1.06x | $245.46K |
| NIOX Group PLC (NIOX) | $81.90 Million | 19.66% | 0.20x | $2.89 Million |
| Polarean Imaging Plc (POLX) | $8.73 Million | -75.05% | 0.25x | $11.75K |
| Rua Life Sciences PLC (RUA) | $6.91 Million | -569.75% | 0.34x | $147.24K |
| Smith & Nephew PLC (SN) | $2.77 Billion | 22.18% | 0.71x | $116.97 Million |
| Surgical Innovations Group plc (SUN) | $1.06 Million | -5.40% | 0.59x | $53.91K |
About AOTI Inc
AOTI, Inc., together with its subsidiaries, produces, rents, and sells medical devices to resolve severe acute and chronic wounds for customers worldwide. The company offers topical wound oxygen solutions for use in the institutional and the home care settings to improve the health, well-being, and independence of patients; and NEXA, an negative pressure wound therapy system. AOTI, Inc. was incor… Read more